CD8A and neoplasm: Ablation of YTHDF2 in TAMs suppressed tumor growth by reprogramming TAMs toward an antitumoral phenotype and increasing their antigen cross-presentation abilities, which in turn enhanced CD8+ T cell-mediated anti-tumor immune responses.